These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 14526090)

  • 1. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience.
    Maas M; van Kuijk C; Stoker J; Hollak CE; Akkerman EM; Aerts JF; den Heeten GJ
    Radiology; 2003 Nov; 229(2):554-61. PubMed ID: 14526090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.
    Maas M; Hollak CE; Akkerman EM; Aerts JM; Stoker J; Den Heeten GJ
    AJR Am J Roentgenol; 2002 Oct; 179(4):961-5. PubMed ID: 12239046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraobserver and interobserver variability of the bone marrow burden (BMB) score for the assessment of disease severity in Gaucher disease. Possible impact of reporting experience.
    Lai JKC; Robertson PL; Goh C; Szer J
    Blood Cells Mol Dis; 2018 Feb; 68():121-125. PubMed ID: 28187999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-MRI score: A simple method for assessing bone marrow involvement in Gaucher disease.
    Roca M; Mota J; Alfonso P; Pocoví M; Giraldo P
    Eur J Radiol; 2007 Apr; 62(1):132-7. PubMed ID: 17161930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease.
    Johnson LA; Hoppel BE; Gerard EL; Miller SP; Doppelt SH; Zirzow GC; Rosenthal DI; Dambrosia JM; Hill SC; Brady RO
    Radiology; 1992 Feb; 182(2):451-5. PubMed ID: 1732964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-year follow-up.
    Elstein D; Haims AH; Zahrieh D; Cohn GM; Zimran A
    Blood Cells Mol Dis; 2014; 53(1-2):56-60. PubMed ID: 24581483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score.
    Robertson PL; Maas M; Goldblatt J
    AJR Am J Roentgenol; 2007 Jun; 188(6):1521-8. PubMed ID: 17515371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Bone Marrow Involvement in Treated Gaucher Disease With Proton MR Spectroscopy: Correlation With Bone Marrow MRI Scores and Clinical Status.
    Jaramillo D; Bedoya MA; Wang DJ; Pena AH; Delgado J; Jaimes C; Ho-Fung V; Kaplan P
    AJR Am J Roentgenol; 2015 Jun; 204(6):1296-302. PubMed ID: 26001241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.
    Hollak C; Maas M; Akkerman E; den Heeten A; Aerts H
    Blood Cells Mol Dis; 2001; 27(6):1005-12. PubMed ID: 11831867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.
    Laudemann K; Moos L; Mengel KE; Lollert A; Reinke J; Brixius-Huth M; Wagner D; Düber C; Staatz G
    Rofo; 2015 Dec; 187(12):1093-8. PubMed ID: 26200566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaucher disease status and treatment assessment: pilot study using magnetic resonance spectroscopy bone marrow fat fractions in pediatric patients.
    Degnan AJ; Ho-Fung VM; Wang DJ; Ficicioglu C; Jaramillo D
    Clin Imaging; 2020 Jul; 63():1-6. PubMed ID: 32120306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for Belgian MR centers for monitoring of bone marrow involvement in patients with Gaucher disease.
    Vanhoenacker FM; Maas M
    JBR-BTR; 2006; 89(6):321-4. PubMed ID: 17274591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fat fraction quantification of bone marrow in the lumbar spine using the LiverLab assessment tool in healthy adult volunteers and patients with Gaucher disease.
    Gan C; Robertson PL; Lai JKC; Szer J
    Intern Med J; 2023 Jul; 53(7):1163-1169. PubMed ID: 35762150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow abnormalities of foot and ankle: STIR versus T1-weighted contrast-enhanced fat-suppressed spin-echo MR imaging.
    Schmid MR; Hodler J; Vienne P; Binkert CA; Zanetti M
    Radiology; 2002 Aug; 224(2):463-9. PubMed ID: 12147843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?
    Fedida B; Touraine S; Stirnemann J; Belmatoug N; Laredo JD; Petrover D
    Eur Radiol; 2015 Oct; 25(10):2969-75. PubMed ID: 25875285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow disorders: characterization with quantitative MR imaging.
    Smith SR; Williams CE; Davies JM; Edwards RH
    Radiology; 1989 Sep; 172(3):805-10. PubMed ID: 2772192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values.
    Breault SR; Heye T; Bashir MR; Dale BM; Merkle EM; Reiner CS; Faridi KF; Gupta RT
    AJR Am J Roentgenol; 2013 Mar; 200(3):W297-303. PubMed ID: 23436875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
    Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
    Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MR imaging of the water fraction of normal bone marrow and diffuse bone marrow disease.
    Katsuya T; Inoue T; Ishizaka H; Aoki J; Endo K
    Radiat Med; 2000; 18(5):291-7. PubMed ID: 11128399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers.
    Maas M; Akkerman EM; Venema HW; Stoker J; Den Heeten GJ
    J Comput Assist Tomogr; 2001; 25(5):691-7. PubMed ID: 11584227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.